Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.0
7.8
Journals
Vaccines
Special Issues
Social Media in Immunology and Immunotherapy
share announcement

Social Media in Immunology and Immunotherapy

A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 5179

Special Issue Editors

Dr. Gianluigi Califano

E-Mail Website
Guest Editor
Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli Federico II, Naples, Italy
Interests: social media; immunology; medicine; scientific research
Special Issues, Collections and Topics in MDPI journals
Dr. Simone Morra

E-Mail Website
Co-Guest Editor
1. Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada
2. Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy
Interests: urologic oncology; bladder cancer; kidney cancer; prostate cancer; epidemiology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Social media platforms have become an essential part of our daily lives. Facebook has close to 2.4 billion users, YouTube and Instagram 1 billion, Twitter 330 million and LinkedIn 310 million active users. Moreover, TikTok has become the favorite social media platform in the younger generation. The social media revolution has quickly impacted healthcare, with significant educational, informative, and knowledge exchange implications.

The content analysis of social media platforms in the field of medicine and scientific research currently represents a hot topic for the international literature. In fact, over the last few years, the number of publications focusing on the use and contents of social media for medical/scientific purposes has grown exponentially. This process has also been amplified by the new needs identified due to the pandemic wave.

Currently, the Immunology field has made numerous strides, ensuring the development of different types of vaccine for SARS-Cov2 in just a few months. This is just one of the various goals achieved by this sector: just think of the new existing therapies in modulating the immune system to respond to neoplastic disease.

The aim of this Special Issue is to explore how social media platforms have changed the way we look at Immunology. This Special Issue will cover a broad spectrum of studies aimed at analyzing the medical–scientific contents addressed by the main social media.

Dr. Gianluigi Califano
Dr. Simone Morra
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • social media
  • immunology
  • medicine
  • scientific research

Published Papers (3 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Editorial

Jump to: Research

4 pages, 220 KiB  
Editorial
Social Media Content on Immunology: Is an Assessment by the Scientific Community Required?
by Simone Morra, Francesco Di Bello, Claudia Collà Ruvolo and Gianluigi Califano
Vaccines 2023, 11(2), 473; https://doi.org/10.3390/vaccines11020473 - 17 Feb 2023
Viewed by 1094
Abstract
In recent years, vaccines and immunotherapy have become two of the most promising and effective tools in the fight against a wide range of diseases, from the common cold to cancer [...] Full article
(This article belongs to the Special Issue Social Media in Immunology and Immunotherapy)

Research

Jump to: Editorial

16 pages, 1253 KiB  
Article
Social Media Sentiment about COVID-19 Vaccination Predicts Vaccine Acceptance among Peruvian Social Media Users the Next Day
by Ayse D. Lokmanoglu, Erik C. Nisbet, Matthew T. Osborne, Joseph Tien, Sam Malloy, Lourdes Cueva Chacón, Esteban Villa Turek and Rod Abhari
Vaccines 2023, 11(4), 817; https://doi.org/10.3390/vaccines11040817 - 07 Apr 2023
Cited by 1 | Viewed by 1950
Abstract
Drawing upon theories of risk and decision making, we present a theoretical framework for how the emotional attributes of social media content influence risk behaviors. We apply our framework to understanding how COVID-19 vaccination Twitter posts influence acceptance of the vaccine in Peru, [...] Read more.
Drawing upon theories of risk and decision making, we present a theoretical framework for how the emotional attributes of social media content influence risk behaviors. We apply our framework to understanding how COVID-19 vaccination Twitter posts influence acceptance of the vaccine in Peru, the country with the highest relative number of COVID-19 excess deaths. By employing computational methods, topic modeling, and vector autoregressive time series analysis, we show that the prominence of expressed emotions about COVID-19 vaccination in social media content is associated with the daily percentage of Peruvian social media survey respondents who are vaccine-accepting over 231 days. Our findings show that net (positive) sentiment and trust emotions expressed in tweets about COVID-19 are positively associated with vaccine acceptance among survey respondents one day after the post occurs. This study demonstrates that the emotional attributes of social media content, besides veracity or informational attributes, may influence vaccine acceptance for better or worse based on its valence. Full article
(This article belongs to the Special Issue Social Media in Immunology and Immunotherapy)
►▼ Show Figures

Figure 1

11 pages, 690 KiB  
Article
Immunotherapy for Urological Tumors on YouTubeTM: An Information-Quality Analysis
by Francesco Di Bello, Ernesto Di Mauro, Claudia Collà Ruvolo, Massimiliano Creta, Roberto La Rocca, Giuseppe Celentano, Marco Capece, Luigi Napolitano, Agostino Fraia, Gabriele Pezone, Simone Morra, Ciro Imbimbo, Vincenzo Mirone, Nicola Longo and Gianluigi Califano
Vaccines 2023, 11(1), 92; https://doi.org/10.3390/vaccines11010092 - 30 Dec 2022
Cited by 5 | Viewed by 1689
Abstract
Background: YouTubeTM is an open-access source for mass information. Several previous studies of YouTubeTM videos showed a high rate of misinformation in the urological field. The aim of the current study was to evaluate the quality of information on immunotherapy (IMT) [...] Read more.
Background: YouTubeTM is an open-access source for mass information. Several previous studies of YouTubeTM videos showed a high rate of misinformation in the urological field. The aim of the current study was to evaluate the quality of information on immunotherapy (IMT) for urological tumors uploaded to YouTubeTM. Methods: YouTubeTM videos were searched using nine keyword combinations. The PEMAT, the DISCERN tool, and the Misinformation scale were used to assess the quality of information in YouTubeTM videos about IMT for urological tumors. Descriptive statistics and Kruskal–Wallis, Chi-square, proportion, and Pearson’s tests were performed. Results: According to the selection criteria, 156 YouTubeTM videos were suitable for the analysis and stratified according to topic (urothelial carcinoma vs. renal cell cancer vs. prostate cancer vs. general information on IMT). According to PEMAT A/V, the overall Understandability score was 40% (Inter-Quartile Range [IQR]: 20–61.5) and the overall Actionability score was 0% (IQR: 0–25). According to the DISCERN tool, the overall DISCERN score was 44 (IQR: 39–53.2), defined as “fair”. According to the Misinformation scale, we recorded the lowest median overall score for item 4 (“IMT in multimodality approach”) and item 5 (“Future perspective”). Conclusions: YouTubeTM cannot be recommended as a reliable source of information on IMT for urological malignancies. In addition, YouTubeTM videos contributed to the spread of misinformation by underestimating the role of IMT in a multimodality approach and missing the findings of published clinical trial results. Full article
(This article belongs to the Special Issue Social Media in Immunology and Immunotherapy)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-3
Back to TopTop